DNA Microarray Market Growth, Size, Trends Analysis - By Type, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

DNA Microarray Market Introduction and Overview

According to SPER market research, 'DNA Microarray Market Size- By Source, By Application, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the DNA Microarray Market is predicted to reach 5.11 billion by 2034 with a CAGR of 9.09%.

A DNA microarray is a powerful tool in the laboratory that may be used to simultaneously analyze the expression of thousands of genes. DNA probes are systematically arranged on a small, solid surface, usually a glass slide or a silicon chip. The tiny DNA strands that make up these probes can bind to complementary sequences in a sample. The sample, usually RNA that has been converted to complementary DNA (cDNA), is identified using fluorescent markers prior to being placed on the microarray.

Restraints: However, the market faces obstacles such competition from next-generation sequencing (NGS) technologies, which provide precise and affordable alternatives to DNA microarrays. The high cost of microarray technology, stringent regulatory frameworks, issues with standardization, and a shortage of skilled workers are additional barriers to growth.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Application, By End Use.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Agilent Technologies, Applied Micro Arrays, BIOMERIEUX, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., QIAGEN, Thermo Fisher Scientific, Inc., and others.

DNA Microarray Market Segmentation:

By Type: Based on the Type, Global DNA Microarray Market is segmented as; Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Others.

By Application: Based on the Application, Global DNA Microarray Market is segmented as; Gene Expression Analysis, Genotyping, Others.

By End Use: Based on the End Use, Global DNA Microarray Market is segmented as; Gene Expression Analysis, Genotyping, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Product Code: HLCA2565

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global DNA Microarray Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global DNA Microarray Market

7. Global DNA Microarray Market, By Type, (USD Million) 2021-2034

7.1. Complementary DNA Microarrays
7.2. Oligonucleotide DNA Microarrays
7.3. Others

8. Global DNA Microarray Market, By Application, (USD Million) 2021-2034

8.1. Gene Expression Analysis
8.2. Genotyping
8.3. Others

9. Global DNA Microarray Market, By End Use, (USD Million) 2021-2034

9.1. Gene Expression Analysis
9.2. Genotyping
9.3. Others

10. Global DNA Microarray Market, (USD Million) 2021-2034

10.1. Global DNA Microarray Market Size and Market Share

11. Global DNA Microarray Market, By Region, (USD Million) 2021-2034

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Agilent Technologies
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Applied Micro Arrays
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. BIOMERIEUX
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. F. Hoffmann-La Roche Ltd.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Illumina, Inc.
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Merck KGaA
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. PerkinElmer, Inc.
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. QIAGEN
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Thermo Fisher Scientific, Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Others